330 related articles for article (PubMed ID: 22493738)
1. A genetic variant in long non-coding RNA HULC contributes to risk of HBV-related hepatocellular carcinoma in a Chinese population.
Liu Y; Pan S; Liu L; Zhai X; Liu J; Wen J; Zhang Y; Chen J; Shen H; Hu Z
PLoS One; 2012; 7(4):e35145. PubMed ID: 22493738
[TBL] [Abstract][Full Text] [Related]
2. The expression of long non coding RNA genes is associated with expression with polymorphisms of HULC rs7763881 and MALAT1 rs619586 in hepatocellular carcinoma and HBV Egyptian patients.
Motawi TMK; El-Maraghy SA; Sabry D; Mehana NA
J Cell Biochem; 2019 Sep; 120(9):14645-14656. PubMed ID: 31009106
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphism of interleukin-16 influences susceptibility to HBV-related hepatocellular carcinoma in a Chinese population.
Li S; Deng Y; Chen ZP; Huang S; Liao XC; Lin LW; Li H; Peng T; Qin X; Zhao JM
Infect Genet Evol; 2011 Dec; 11(8):2083-8. PubMed ID: 22019522
[TBL] [Abstract][Full Text] [Related]
4. Genetic variants in IL12 influence both hepatitis B virus clearance and HBV-related hepatocellular carcinoma development in a Chinese male population.
Tan A; Gao Y; Yao Z; Su S; Jiang Y; Xie Y; Xian X; Mo Z
Tumour Biol; 2016 May; 37(5):6343-8. PubMed ID: 26631030
[TBL] [Abstract][Full Text] [Related]
5. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
[TBL] [Abstract][Full Text] [Related]
6. Association of NTCP polymorphisms with clinical outcome of hepatitis B infection in Thai individuals.
Chuaypen N; Tuyapala N; Pinjaroen N; Payungporn S; Tangkijvanich P
BMC Med Genet; 2019 May; 20(1):87. PubMed ID: 31117968
[TBL] [Abstract][Full Text] [Related]
7. Expression quantitative trait loci for TNFRSF10 influence both HBV infection and hepatocellular carcinoma development.
Wen J; Song C; Liu J; Chen J; Zhai X; Hu Z
J Med Virol; 2016 Mar; 88(3):474-80. PubMed ID: 26297860
[TBL] [Abstract][Full Text] [Related]
8. Expression quantitative trait loci in long non-coding RNA ZNRD1-AS1 influence both HBV infection and hepatocellular carcinoma development.
Wen J; Liu Y; Liu J; Liu L; Song C; Han J; Zhu L; Wang C; Chen J; Zhai X; Shen H; Hu Z
Mol Carcinog; 2015 Nov; 54(11):1275-82. PubMed ID: 25110835
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-21 gene polymorphisms and chronic hepatitis B infection in a Chinese population.
Yao JY; Chao K; Li MR; Wu YQ; Zhong BH
World J Gastroenterol; 2015 Apr; 21(14):4232-9. PubMed ID: 25892873
[TBL] [Abstract][Full Text] [Related]
10. PNPLA3 rs738409 is not associated with the risk of hepatocellular carcinoma and persistent infection of hepatitis B virus (HBV) in HBV-related subjects: A case-control study and meta-analysis on Asians.
Wang P; Wu C; Li Y; Gong Y; Shen N
Gene; 2020 Jun; 742():144585. PubMed ID: 32173542
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms in the miR-372 (rs12983273) and LncRNA HULC (rs7763881) genes and susceptibility to Hepatitis B virus (HBV) infection.
Shahen SM; Elshenawy SZ; Mohamed SE; Talaat RM
Mol Biol Rep; 2021 Dec; 48(12):7901-7906. PubMed ID: 34677712
[TBL] [Abstract][Full Text] [Related]
12. Genetic variant in visfatin gene promoter contributes to reduced risk of hepatocellular carcinoma in a Chinese population.
Wu Z; Sun Y; Huang Y; Zhu S; Feng Y; Ye H; Liu C; Tang S
Oncotarget; 2016 Nov; 7(47):77968-77977. PubMed ID: 27792999
[TBL] [Abstract][Full Text] [Related]
13. C-reactive protein genetic polymorphisms increase susceptibility to HBV-related hepatocellular carcinoma in a Chinese population.
Peng Q; Ren S; Lao X; Lu Y; Zhang X; Chen Z; Qin X; Li S
Tumour Biol; 2014 Oct; 35(10):10169-76. PubMed ID: 25027406
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide association study of hepatocellular carcinoma in Southern Chinese patients with chronic hepatitis B virus infection.
Chan KY; Wong CM; Kwan JS; Lee JM; Cheung KW; Yuen MF; Lai CL; Poon RT; Sham PC; Ng IO
PLoS One; 2011; 6(12):e28798. PubMed ID: 22174901
[TBL] [Abstract][Full Text] [Related]
15. Association between interleukin-21 gene polymorphisms (rs12508721) and HBV-related hepatocellular carcinoma.
Zhang QX; Li SL; Yao YQ; Li TJ
Int J Immunogenet; 2016 Jun; 43(3):151-8. PubMed ID: 27122304
[TBL] [Abstract][Full Text] [Related]
16. HBV-related hepatocellular carcinoma susceptibility gene KIF1B is not associated with development of chronic hepatitis B.
Zhong R; Tian Y; Liu L; Qiu Q; Wang Y; Rui R; Yang BF; Duan SY; Shi JX; Miao XP; Wang L; Li H
PLoS One; 2012; 7(2):e28839. PubMed ID: 22363396
[TBL] [Abstract][Full Text] [Related]
17. CDC25B is associated with the risk of hepatocellular carcinoma, but not related to persistent infection of hepatitis B virus in a Chinese population.
Wang P; Peng J; Gong Y; Shen N
Mol Biol Rep; 2020 May; 47(5):3361-3368. PubMed ID: 32248384
[TBL] [Abstract][Full Text] [Related]
18. Gene polymorphisms of TLR2 and TLR3 in HBV clearance and HBV-related hepatocellular carcinoma in a Chinese male population.
Chen D; Xie W; Lu Y; Su S; Nong L; Jia Y; Liu Y; Zhou W; Wang H; Tan A
Int J Biol Markers; 2017 May; 32(2):e195-e201. PubMed ID: 28009434
[TBL] [Abstract][Full Text] [Related]
19. A genetic variant in microRNA-122 regulatory region confers risk for chronic hepatitis B virus infection and hepatocellular carcinoma in Han Chinese.
Liu Y; Xie K; Wen J; Deng M; Li J; Hu Z
J Med Virol; 2014 Oct; 86(10):1669-74. PubMed ID: 24995424
[TBL] [Abstract][Full Text] [Related]
20. Association of twelve polymorphisms in three onco-lncRNA genes with hepatocellular cancer risk and prognosis: A case-control study.
Wang BG; Xu Q; Lv Z; Fang XX; Ding HX; Wen J; Yuan Y
World J Gastroenterol; 2018 Jun; 24(23):2482-2490. PubMed ID: 29930469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
